[ Price : $8.95]
FDA Webview editor Jim Dickinson sees a disturbing parallel between the Penn State sex scandal and FDAs equally toxic culture of l...[ Price : $8.95]
FDA accepts for review a Genentech NDA for vismodegib, indicated for treating adults with advanced basal cell carcinoma.[ Price : $8.95]
FDA says that ACCORD trial results show that Abbotts Trilipex may not lower a patients risk of heart attack or stroke.[ Price : $8.95]
FDA says that Mizuhos recall of its OSI modular table systems due to the potential for patient injuries is a Class 1 recall.[ Price : $8.95]
CDER director Janet Woodcock discusses her concept of building quality in cooperatively to the structure of drug clinical trials....[ Price : $8.95]
The Congressional Budget Office estimates a reduction in federal budget deficits of nearly $5 billion over 10 years from a bill to...[ Price : $8.95]
FDA accepts for review a QRxPharma Limited 505(b)(2) NDA for MoxDuo (morphine and oxycodone) IR, indicated for treating moderate t...[ Price : $8.95]
The Generic Pharmaceutical Association blasts research funded by Pharmaceutical Research and Manufacturers of America calling on C...